Haig Yeghiaian, country manager of LEO Pharma Brazil, details his strategic mission and objectives since he took over the helm of the affiliate in November 2016 as well as the key opportunities and structural rooms for improvement he identifies within the promising Brazilian dermatology area, before highlighting how he wants LEO Pharma Brazil to actively contribute to the strengthening of the domestic healthcare ecosystem in this therapeutic area.
You display an eye-catching industry experience forged among leading multinational companies, especially in the renal and virology fields. Could you introduce yourself to our international readers and explain what motivated you to embark on this new adventure at the helm of LEO Pharma Brazil?
"Latin America in general and Brazil in particular undoubtedly hold a huge development potential in the dermatology field."
